Investigating how brain cells develop and their role in brain tumors
Shared mechanisms of astrocyte maturation in development and glioblastoma
This study is looking at how certain brain cells, called astrocytes, develop in people with glioblastoma, a tough type of brain cancer, to find ways to help these cells mature better and potentially lead to new treatments for the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10886096 on NIH RePORTER |
What this research studies
This research focuses on glioblastoma, the most aggressive brain tumor in adults, and explores how the development of brain cells, specifically astrocytes, is linked to this cancer. By examining the molecular triggers that guide the maturation of these cells, the study aims to identify key transcription factors that could potentially restart the maturation process in glioblastoma-affected astrocytes. The approach involves manipulating the expression of these factors to see if they can induce earlier maturation in immature astrocytes, using advanced techniques like ATAC sequencing to analyze gene activity. Patients may benefit from insights that could lead to new therapeutic strategies targeting glioblastoma.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are adults diagnosed with glioblastoma or those with related neurological conditions.
Not a fit: Patients with non-cancerous brain conditions or those outside the age range of 21+ years may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that improve outcomes for patients with glioblastoma.
How similar studies have performed: Other research has shown promise in using transcription factors to influence cell maturation, suggesting that this approach may yield significant insights.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Sloan, Steven a — Emory University
- Study coordinator: Sloan, Steven a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.